1. GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents.
- Author
-
Klein AK, Austin EW, Cunningham MJ, Dvorak D, Gatti S, Hulls SK, Kiss L, Kruegel AC, Marek GJ, Papp M, Sporn J, and Hughes ZA
- Subjects
- Animals, Male, Rats, Mice, Administration, Oral, Rats, Sprague-Dawley, Biological Availability, Ketamine administration & dosage, Ketamine pharmacology, Depression drug therapy, Motor Activity drug effects, Dose-Response Relationship, Drug, Mice, Inbred C57BL, Excitatory Amino Acid Antagonists administration & dosage, Excitatory Amino Acid Antagonists pharmacology, Excitatory Amino Acid Antagonists pharmacokinetics, Humans, Antidepressive Agents administration & dosage, Antidepressive Agents pharmacology, Antidepressive Agents pharmacokinetics, Receptors, N-Methyl-D-Aspartate antagonists & inhibitors
- Abstract
The NMDA receptor (NMDAR) antagonist ketamine has shown great potential as a rapid-acting antidepressant; however, its use is limited by poor oral bioavailability and a side effect profile that necessitates in-clinic dosing. GM-1020 is a novel NMDAR antagonist that was developed to address these limitations of ketamine as a treatment for depression. Here, we present the preclinical characterization of GM-1020 alongside ketamine, for comparison. In vitro, we profiled GM-1020 for binding to NMDAR and functional inhibition using patch-clamp electrophysiology. In vivo, GM-1020 was assessed for antidepressant-like efficacy using the Forced Swim Test (FST) and Chronic Mild Stress (CMS), while motor side effects were assessed in spontaneous locomotor activity and on the rotarod. The pharmacokinetic properties of GM-1020 were profiled across multiple preclinical species. Electroencephalography (EEG) was performed to determine indirect target engagement and provide a potentially translational biomarker. These results demonstrate that GM-1020 is an orally bioavailable NMDAR antagonist with antidepressant-like efficacy at exposures that do not produce unwanted motor effects., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF